Specialty Pharma ApS: Financial statements 2020
CVR: 38476599
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Specialty Pharma ApS (CVR 38476599) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 943,766 and a net result of DKK -39,453 compared with DKK -14,283 the year before. That is an increase of 15.2% compared with the year before. Equity in the 2020 report amounted to DKK 16,920. The solvency ratio was 9.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 943,766
- Profit/Loss
- DKK -39,453
- Equity
- DKK 16,920
- Total Assets
- DKK 179,460
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 944 t. | -39 t. | 17 t. | 2 |
| 2019 | - | 819 t. | -14 t. | 56 t. | 2 |
| 2018 | - | 110 t. | -2 t. | 71 t. | 1 |
Official annual report
How creditworthy is Specialty Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Specialty Pharma ApS has published its annual report for 2019. Gross profit came to DKK 819,270, and the net result was DKK -14,283.
About Specialty Pharma ApS
Specialty Pharma ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Ulla Haaning Singapuri. The company is owned by Ulla Haaning Singapuri. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 216,735 and a net result of DKK -58,566 compared with DKK -53,758 the year before. Equity in the 2025 report amounted to DKK -17,816.